Wegovy sales surge, COVID vax sales sink, and 'junk' patents: Pharma news roundup

Novo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna stock surged on Thursday after its first-quarter earnings report blew past Wall Street’s

By: Quartz India

May 04 2024
10
4373 Views

Wegovy sales surge, COVID vax

The skyrocketing popularity of the diabetes drug Ozempic has put a heavy burden on public spending in Denmark, the home country of the drugs producer Novo Nordisk. In response, the Danish Medicines A… [+140 chars]